IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AKER BIOMARINE AS
`Petitioner
`
`v.
`
`NEPTUNE TECHNOLOGIES AND BIORESSOURCES INC.
`Patent Owner
`
`
`CASE IPR: Unassigned
`
`AKER BIOMARINE AS’S EXHIBIT LIST
` (INTER PARTES REVIEW OF U.S. PATENT NO. 8,278,351)
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`1
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AKER BIOMARINE AS
`Petitioner
`
`v.
`
`NEPTUNE TECHNOLOGIES AND BIORESSOURCES INC.
`Patent Owner
`
`
`CASE IPR: Unassigned
`
`AKER BIOMARINE AS’S EXHIBIT LIST
` (INTER PARTES REVIEW OF U.S. PATENT NO. 8,278,351)
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`1
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`
`
`U.S. Pat. No. 8,278,351 to Sampalis (“’351”)
`
`WO 00/23546 to Beaudoin (“Beaudoin I”)
`
`Canadian Application 2,251,265 to Beaudoin (“Beaudoin II”)
`
`Certified translation of Ex. 1070: Japanese Unexamined Patent
`Application Publication No. 02-215351, titled Krill Phospholipids
`Fractioning Method (“Maruyama,”); Certificate of Translation
`provided as Ex. 1071.
`
`Certified translation of Ex. 1072: Fisheries Agency, General
`Report on Research and Development of Techniques in Processing
`and Utilization of Marine Products, Chapter 6, Development of
`technology for recovery of valuable substances (astaxanthin) from
`krill, by Takao Fujita, pp. 273-307 (March 1985) (“Fujita”) ;
`Certificate of Translation provided as Ex. 1073.
`
`Fricke et al., Lipid, Sterol, and Fatty Acid Composition of
`Antarctic Krill, Lipids, Vol. 19, No. 11, pp. 821-827 (1984)
`(“Fricke”)
`
`Bottino, N.R., “Lipid Composition of Two Species of Antarctic
`Krill: Euphausia Superba and E. Crystallorophias,” Comp.
`Biochem. Physiol., 1975, Vol. 50B, pp. 479-484 (“Bottino”)
`
`2
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`
`
`Canadian Patent No. 1098900, titled Method for the Processing of
`Krill to Produce Protein, Lipids and Chitin (“Rogozhin”)
`
`Itano Refrigerated Food Co., Ltd., Bio & High Technology
`Announcement and Natural Astaxanthin & Krill Lecithin, pp. 1-16
`(on or before December 28, 1994) (“Itano”)
`
`WO97/39759 to Stoll (“Stoll”)
`
`Final Prospectus dated May 11, 2001 (“Final Prospectus”)
`
`“Neptune Technologies & Bioressources Soon to Obtain a Major
`Patent in Over 30 Countries” (“2011 Press Release,”)
`
`Le Grandois et al., Investigation of Natural Phosphatidylholine
`Sources: Separation and Identification by Liquid Chromatography
`-Electrospray Ionization-Tandem Mass Spectrometry (LC-ESI-
`MS2) of Molecular Species, J. Agric. Food Chem., 57, 6014-20
`(2009) (“Le Grandois”)
`
`Certified translation of Ex. 1074: Japanese Patent No. 60-153779,
`entitled “Nutritional Supplement” (“Fukuoka ”); Certificate of
`Translation provided as Ex. 1075
`
`Certified translation of Ex. 1076: Japanese Patent Publication No.
`H08-231391, entitled “Medicine for Improvement of Dementia
`
`3
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`Symptoms” (“Yasawa”); Certificate of Translation provided as
`Ex. 1077.
`
`Suzuki, T. and Shibata, N., “The utilization of Antarctic krill for
`human food,” Food Rev. Int’l, 6:1, 119-147 (1990) (“Suzuki”)
`
`Bergelson (ed.), Lipid Biochemical Preparations, Chapter I.1, pp.
`1-13 (1980) (“Bergelson”)
`
`WHO News and Activities, Bulletin of the World Health
`Organization, 73(4), pp. 547-51 (1995) (“WHO Bulletin”)
`
`Bell and Dick, Molecular Species Composition of the Major
`Diacyl Glycerophospholipids from Muscle, Liver, Retina and
`Brain of Cod (Gadus morhua), Lipids, Vol. 26, No. 8, pp. 565-
`573 (1991) (“Bell and Dick”)
`
`Henderson et al., Lipid Composition of the Pineal Organ from
`Rainbow Trout (Oncorhynchus mykiss), Lipids, Vol. 29, No. 5,
`pp. 311-317 (1994) (“Henderson ”)
`
`Bell, Molecular Species Analysis of Phosphoglycerides from the
`Ripe Roes of Cod, Lipids, Vol. 24, No. 7 (1989)
`
`Takahashi et al., Compositional Changes in Molecular Species of
`Fish Muscle Phosphatidylcholine During Storage, Bull. Fac. Fish.
`
`4
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`Hokkaido Univ. 37(1), 80-84 1986.
`
`Takahashi et al., Prediction of Relative Retention Value of the
`Individual Molecular Species of Diacyl Glycerolipid on High
`Performance Liquid Chromatography, Bull. Fac. Fish. Hokkaido
`Univ. 38(4), 398-404. 1987
`
`Lin et al., Effect of Dietary N-3 Fatty Acids Upon the
`PhospholipidMolecular Species of the Monkey Retina, Invest
`Ophthalmol Vis Sci. 1994;35:794-803
`
`Farkas, Composition and Physical State of Phospholipids in
`Calanoid Copepods from India and Norway, LIPIDS, Vol. 23, No.
`6 (1988)
`
`Bell, Molecular Species Composition of Phosphatidylcholine from
`Crypthecodinium cohnii in Relation to Growth Temperature
`Lipids 25, 115-118 (1990)
`
`Buda, Structural order of membranes and composition of
`phospholipids in fish brain cells during thermal acclimatization,
`Proc. Natl. Acad. Sci. USA Vol. 91, pp. 8234-8238, August 1994
`
`Takahashi et al., Molecular Species of Fish Muscle Lecithin,
`Bulletin of the Japanese Society of Scientific Fisheries 48(12),
`
`5
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1803-1814 (1982)
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`Tocher, Chapter 6, Glycerophospholipid metabolism,
`Biochemistry and molecular biology of fishes, vol. 4, Hochachka
`and Mommsen (eds.)(1995)
`
`Tanaka, Biosynthesis of 1,2-dieicosapentaenoyl-sn-glycero-3-
`phosphocholine in Caenorhabditis elegans, Eur. J. Biochem. 263,
`189±194 (1999)
`
`Winther et al., Elucidation of Phosphatidylcholine Composition in
`Krill Oil Extracted from Euphausia superba, Lipids 46(1):25-36
`(2011)(“Winther”)
`
`Eichberg, “Lecithin – It Manufacture and Use in the Fat and Oil
`Industry,” Oils and Soap 51-54, 1939 (“Eichberg”)
`
`Balassa et al., Microencapsulation in the Food Industry, Critical
`Reviews in Food Technology, 2:2, 245-265 (1971)(“Balassa”)
`
`Buchi R-220 Rotovapor® Manual
`
`Johnson and Lucas, Comparison of Alternative Solvents for Oils
`Extraction, JAOCS 60(2):229-242 (1983)
`
`1036
`
`U.S. Pat. No. 4,714,571
`
`
`
`6
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`Grit et al., Int. J. Pharmaceutics 50:1-6 (1989)
`
`Herman and Groves, Pharmaceutical Research 10(5):774-776
`(1993)
`
`Watanabe et al., Effective Components in Cuttlefish Meal and
`Raw Krill for Improvement of Quality of Red Seabream Pagrus
`major Eggs, Nippon Suisan Gakkaishi 57(4):681-694
`(1991)(“Watanabe”)
`
`Declaration of Dr. Richard van Breemen in Support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Van Breemen”)
`
`Declaration of Dr. Suzanne Budge in Support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Budge”)
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes
`Review of U.S. Pat. No. 8,278,351
`
`Expert Witness Report of Dr. Theodore Welch submitted in
`relation to ITC Investigation No. 337-TA-877 (“Welch”)
`
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of
`U.S. Pat. No. 8,278,351 (“Moore”)
`
`AKBM
`Exhibit No.
`
`1037
`
`1038
`
`1039
`
`1040
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of
`
`
`
`7
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`U.S. Pat. No. 8,278,351 (“Lee”)
`
`Declaration of Dr. Ivar Storrø in support of Inter Partes Review of
`U.S. Pat. No. 8,278,351 (“Storrø”)
`
`Declaration of Bjorn Ole Haugsgjerd submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Haugsgjerd ‘348
`Decl.”)
`
`Supplemental Declaration of Bjorn Ole Haugsgjerd submitted
`during inter partes reexamination of parent patent U.S. 8,030,348
`(“Haugsgjerd ‘348 Supp. Decl.”)
`
`Declaration of Dr. Thomas Gundersen submitted during inter
`partes reexamination of parent patent U.S. 8,030,348 (“Gundersen
`Decl.”)
`
`Supplemental Declaration of Dr. Thomas Gundersen submitted
`during inter partes reexamination of parent patent U.S. 8,030,348
`(“Gundersen Supp. Decl.”)
`
`Declaration of Dr. Earl White submitted during prosecution of
`parent patent U.S. 8,030,348 (“2011 White Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`prosecution of parent patent U.S. 8,278,351 (“White Supp. Decl.”)
`
`8
`
`1046
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`1058
`
`1059
`
`1060
`
`
`
`Declaration of Dr. Jacek Jaczynski from inter partes reexamination
`of the parent patent U.S. 8,030,348 (“Jaczynski Reexam. Decl.”)
`
`Declaration of Dr. Yeboah submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Yeboah Reexam
`Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`inter partes reexamination of parent patent U.S. 8,030,348 (“White
`Supp. Reexam. Decl.”)
`
`Declaration of Dr. Shahidi submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (Shahidi Reexam.
`Decl.”
`
`Declaration of Dr. Tina Sampalis submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (Sampalis”)
`
`Declaration of Dr. Yeboah submitted during prosecution of parent
`patent U.S. 8,278,351 (“Yeboah ‘351 Decl.”)
`
`Declaration of Dr. Shahidi submitted during prosecution of parent
`patent U.S. 8,278,351 (Shahidi ‘351 Decl.”)
`
`Declaration of Dr. Jaczynski submitted during prosecution of
`parent patent U.S. 8,278,351 (Jaczynski ‘351 Decl.”)
`
`9
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1061
`
`1062
`
`1063
`
`1064
`
`1065
`
`1066
`
`1067
`
`1068
`
`1069
`
`1070
`
`
`
`April 2, 2012 Response to Office Action, ‘351 patent
`
`Provisional Application No. 60/307,842 (Priority document for the
`‘351 patent)
`
`Office Action dated January 5, 2012, ‘351 patent
`
`Action Closing Prosecution, ‘348 patent
`
`Grant of Request for Ex parte Reexamination of the ‘351 patent
`
`Declaration of Dr. Van Breemen submitted during Ex parte
`Reexamination of the ‘351 patent (Van Breemen ‘351 Reexam.
`Decl.”
`
`Declaration of Dr. Van Breemen submitted during Inter partes
`Reexamination of the ‘348 patent (Van Breemen ‘348 Reexam
`Decl.”
`
`Medina et al., J. Amer. Oil Chem. Soc. 71(5):479-82 (1994)
`
`U.S. Patent No. 8,030,348
`
`Japanese Unexamined Patent Application Publication No. 02-
`215351, titled Krill Phospholipids Fractioning Method; Japanese
`language document
`
`10
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`AKBM
`Exhibit No.
`
`1071
`
`1072
`
`1073
`
`1074
`
`1075
`
`1076
`
`
`
`Certification of translation of Ex. 1070: Japanese Unexamined
`Patent Application Publication No. 02-215351
`
`Fisheries Agency, General Report on Research and Development
`of Techniques in Processing and Utilization of Marine Products,
`Chapter 6, Development of technology for recovery of valuable
`substances (astaxanthin) from krill, by Takao Fujita, pp. 273-307
`(March 1985); Japanese language document
`
`Certificate of translation of Ex. 1072: Fisheries Agency, General
`Report on Research and Development of Techniques in Processing
`and Utilization of Marine Products, Chapter 6, Development of
`technology for recovery of valuable substances (astaxanthin) from
`krill, by Takao Fujita, pp. 273-307 (March 1985); Japanese
`language document
`
`Japanese Patent No. 60-153779, entitled “Nutritional
`Supplement”; Japanese language document
`
`Certificate of translation of Ex. 1074: Japanese Patent No. 60-
`153779, entitled “Nutritional Supplement”
`
`Japanese Patent Publication No. H08-231391, entitled “Medicine
`for Improvement of Dementia Symptoms”; Japanese language
`document
`
`11
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`Description
`
`Certificate of translation of Ex. 1076: Japanese Patent Publication
`No. H08-231391, entitled “Medicine for Improvement of
`Dementia Symptoms”
`
`Folch, et al., A Simple Method for the Isolation and Purification of
`Total Lipids from Animal Tissues. J. Biol. Chem., 226, 497-509
`(1957)
`
`Declaration of Dr. Chong Lee submitted during inter partes
`reexamination of parent patent U.S. 8,030,348 (“Yeboah Reexam
`Decl.”)
`
`Declaration of Bjorn Ole Haugsgjerd in support of Inter Partes
`Review of U.S. Pat. No. 8,278,351 (“Haugsgjerd”)
`
`AKBM
`Exhibit No.
`
`1077
`
`1078
`
`1079
`
`1080
`
`
`
`
`
`
`
`
`
`
`Dated: October 1, 2013
`
`
`
`
`
`
`
`
`
`
`CASIMIR JONES SC
`2275 Deming Way, Suite 310
`Middleton, WI 53562
`(608) 662-1277
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/John Mitchell Jones/
`John Mitchell Jones
`Registration No. 44,174
`Attorneys for Petitioner
`Registration No. 44,174
`
`
`
`
`
`
`
`12
`
`
`
`AKER BIOMARINE AS EXHIBIT LIST
`Inter Partes Review of U.S. Patent No. 8,278,351
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that “AKER BIOMARINE AS’S
`
`EXHIBIT LIST (INTER PARTES REVIEW OF U.S. PATENT NO. 8,278,351),”
`
`along with Exhibits 1001 – 1080, were served in their entirety by United States
`
`Postal Service Express Mail No. EM656156950US this 1st day of October 2013 on
`
`the following:
`
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, NW
`Suite 700
`Washington, DC 20004
`Patent owner’s correspondence address
`Of record for U.S. Patent No. 8,278,351
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CASIMIR JONES SC
`
`/John Mitchell Jones/
`John Mitchell Jones
`Registration No. 44,174
`Attorneys for Petitioner
`
`
`Dated: October 1, 2013
`
`
`
`
`
`
`
`
`
`
`
`
`2275 Deming Way, Suite 310
`Middleton, WI 53562
`(608) 662-1277
`
`
`
`
`13
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
